Business Context and Reporting Period
This Form 8-K Current Report, filed on February 6, 2023, covers events occurring on February 3, 2023, for Marchex, Inc. (Nasdaq: MCHX). The filing primarily addresses significant changes in executive leadership and board composition, marking a transition from a co-CEO structure to a single CEO model.
Key Financial Metrics and Compensation
The filing does not report operational financial metrics such as revenue, profit, cash flow, or debt levels. Instead, it details specific compensation arrangements for new and departing executives:
- Edwin A. Miller (New CEO): Annual base salary of $425,000. Target annual bonus of $376,250 (100% attainment), with a maximum of 195%. Bonus targets are weighted equally (33 1/3%) across new revenue, total revenue, and adjusted OIBA.
- Equity Grants (Miller): 375,000 shares in a Performance Option (vesting over 5 years with acceleration triggers) and 300,000 shares in a standard Option (vesting over 4 years).
- Russell C. Horowitz (Chairman/Consultant): Monthly consulting fee of $21,250 under a one-year agreement.
- John Roswech (Former CRO): Consulting fee of $33,333 per month for six months plus 50,000 shares of restricted stock.
Material Changes Versus Prior Period
The filing reports a complete restructuring of the company's top leadership effective February 3, 2023:
- CEO Appointment: Edwin A. Miller was appointed Chief Executive Officer, replacing the previous co-CEO arrangement.
- President Appointment: Ryan Polley was appointed President while continuing as Chief Operating Officer.
- Board Changes: Russell C. Horowitz (former Co-CEO) continues as Chairman of the Board. Michael Arends (former Co-CEO) was appointed Vice Chairman of the Board and continues as Principal Financial Officer.
- Departure: John Roswech resigned as Chief Revenue Officer to transition into a six-month consulting role.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, revenue outlook, or specific risk factors beyond the standard definitions of "Cause" for termination and "Change in Control" within the executive agreements. The Performance Option granted to the new CEO includes specific acceleration triggers tied to:
- Revenue exceeding 120% or 127% of the grant year level.
- Adjusted OIBA exceeding specified multiples.
- Share price exceeding 150% or 160% of the grant year average for 20 consecutive trading days.
Important Facts for Investor Verification
- Verify the exact closing stock price on February 3, 2023, to determine the exercise price for the 675,000 total options granted to the new CEO.
- Confirm the specific "adjusted OIBA" multiples required for the CEO's performance option acceleration, as the filing states "specified multiples" without listing the exact figures.
- Monitor the transition of sales leadership following the resignation of the Chief Revenue Officer and the commencement of his consulting role.
- Review the attached press release (Exhibit 99.1) for any additional strategic commentary not included in the 8-K text.